Reliance Life Sciences Private Limited
Form 483 issued February 27, 2026 · Navi Mumbai, India
- Inspection
- Feb 19 – Feb 27, 2026
- Investigators
- Ashar P. Parikh· Eileen A. Liu
- Observations
- 3
- Pages
- 10
- FEI number
- 3009510975
In short: On February 27, 2026, FDA issued a Form 483 with 3 observations to Reliance Life Sciences Private Limited in Navi Mumbai, India (FEI 3009510975) after an inspection that ran Feb 19 – Feb 27, 2026. The investigators were Ashar P. Parikh and Eileen A. Liu. Most observations concern laboratory controls and production.
At a glance
Laboratory controls and production account for 2 of 3 observations.
What FDA observed
Preview: the opening words of each observationDashed: section inferred by FDA Intel and checked against the regulation text
- 01
Laboratory records do not include complete data derived from all tests, examinations, and assay necessary to…
- 02
Procedures designed to prevent microbiological contamination of drug products purporting to be sterile do not include…
- 03
Written records of investigations into unexplained discrepancies do not always include…
This inspection in context
Ashar P. Parikh
19 documents · 2014–2026
Cites 211.113 (control of microbiological contamination) more than any other section. Most of their documents are for sites in California.
The firmReliance Life Sciences Private Limited history
All 2 documents on file for this site, in date order, with what was cited at each inspection.
Similar 483sOther sites cited under 211.194
See how FDA wrote the same problem up elsewhere.
Questions about this 483
What did FDA find at Reliance Life Sciences Private Limited?
FDA listed 3 observations on this Form 483, mostly about laboratory controls, production and quality system. The opening words of each observation are shown on this page.
Who inspected Reliance Life Sciences Private Limited?
Ashar P. Parikh and Eileen A. Liu are named on this Form 483, for the inspection of Feb 19 – Feb 27, 2026. Each investigator has a profile showing what they cite most.
When was Reliance Life Sciences Private Limited inspected by FDA?
The inspection ran Feb 19 – Feb 27, 2026, and the Form 483 is dated February 27, 2026.
How do I get the full Form 483 for Reliance Life Sciences Private Limited?
Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.